Galectin Therapeutics Inc (GALT): 12 insider purchases in the last two years (1 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Feb 9, 2026 | Eldred Kary Director | 300 | $2.70 | $810 | opportunistic |
| Dec 23, 2025 | Eldred Kary Director | 700 | $3.73 | $2.6K | no history |
| Dec 23, 2025 | Freeman Kevin D Director | 5,500 | $3.55 | $19.5K | no history |
| Dec 23, 2025 | Eldred Kary Director | 700 | $3.73 | $2.6K | no history |
| Dec 23, 2025 | Freeman Kevin D Director | 5,500 | $3.55 | $19.5K | no history |
| Dec 23, 2025 | Freeman Kevin D Director | 5,500 | $3.55 | $19.5K | no history |
| Jul 22, 2025 | Eldred Kary Director | 1,000 | $2.93 | $2.9K | no history |
| Jul 18, 2025 | Freeman Kevin D Director | 5,000 | $2.90 | $14.5K | no history |
| Dec 31, 2024 | Shlevin Harold H. Director | 6,500 | $1.16 | $7.5K | no history |
| Dec 26, 2024 | Freeman Kevin D Director | 10,000 | $0.81 | $8.1K | no history |
| Dec 26, 2024 | Eldred Kary Director | 13,469 | $0.82 | $11.0K | no history |
| Dec 26, 2024 | Zordani Richard A. Jr. Director | 10,000 | $0.82 | $8.2K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.